Victory Capital Management Inc Amneal Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 99,215 shares of AMRX stock, worth $778,837. This represents 0.0% of its overall portfolio holdings.

Number of Shares

99,215

Previous 62,515 58.71%

Holding current value

$778,837

Previous $396,000 108.33%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$6.42 - $8.83 $235,614 - $324,061	36,700 Added 58.71%	99,215 $825,000
Q2 2024 Aug 05, 2024	SELL	$5.36 - $7.11 $485,444 - $643,938	-90,568 Reduced 59.16%	62,515 $396,000
Q1 2024 May 03, 2024	SELL	$5.24 - $6.34 $747,302 - $904,179	-142,615 Reduced 48.23%	153,083 $927,000
Q4 2023 Feb 05, 2024	SELL	$3.36 - $6.21 $45,474 - $84,046	-13,534 Reduced 4.38%	295,698 $1.79 Million
Q3 2023 Nov 06, 2023	BUY	$2.76 - $4.59 $1,120 - $1,863	406 Added 0.13%	309,232 $1.3 Million
Q2 2023 Jul 27, 2023	SELL	$1.33 - $3.1 $339 - $790	-255 Reduced 0.08%	308,826 $957,000
Q1 2023 May 02, 2023	BUY	$1.27 - $2.7 $88,087 - $187,272	69,360 Added 28.93%	309,081 $429,000
Q4 2022 Feb 10, 2023	SELL	$1.96 - $2.61 $187,209 - $249,294	-95,515 Reduced 28.49%	239,721 $477,000
Q4 2022 Feb 09, 2023	BUY	$1.96 - $2.61 $274,345 - $365,326	139,972 Added 71.68%	335,236 $667,000
Q3 2022 Nov 02, 2022	SELL	$2.02 - $3.62 $1.27 Million - $2.28 Million	-629,924 Reduced 76.34%	195,264 $394,000
Q2 2022 Aug 01, 2022	SELL	$3.01 - $4.46 $1.16 Million - $1.72 Million	-385,163 Reduced 31.82%	825,188 $2.62 Million
Q1 2022 May 04, 2022	BUY	$3.9 - $4.89 $119,730 - $150,123	30,700 Added 2.6%	1,210,351 $4.98 Million
Q4 2021 Feb 07, 2022	BUY	$3.95 - $5.85 $671,571 - $994,605	170,018 Added 16.84%	1,179,651 $5.65 Million
Q3 2021 Nov 02, 2021	SELL	$4.31 - $5.64 $3.93 Million - $5.14 Million	-911,857 Reduced 47.46%	1,009,633 $5.39 Million
Q2 2021 Aug 03, 2021	BUY	$5.12 - $6.82 $685,199 - $912,706	133,828 Added 7.49%	1,921,490 $9.84 Million
Q1 2021 May 04, 2021	BUY	$4.74 - $7.38 $7.66 Million - $11.9 Million	1,616,423 Added 943.96%	1,787,662 $12 Million
Q4 2020 Feb 01, 2021	BUY	$3.95 - $5.42 $290,727 - $398,922	73,602 Added 75.38%	171,239 $783,000
Q3 2020 Nov 09, 2020	BUY	$3.54 - $5.27 $179,885 - $267,795	50,815 Added 108.53%	97,637 $379,000
Q2 2020 Aug 07, 2020	SELL	$2.87 - $5.46 $3,969 - $7,551	-1,383 Reduced 2.87%	46,822 $223,000
Q1 2020 May 04, 2020	SELL	$2.46 - $5.35 $16,981 - $36,931	-6,903 Reduced 12.53%	48,205 $168,000
Q4 2019 Feb 06, 2020	BUY	$2.65 - $5.56 $15,423 - $32,359	5,820 Added 11.81%	55,108 $266,000
Q4 2019 Feb 04, 2020	SELL	$2.65 - $5.56 $1,998 - $4,192	-754 Reduced 1.51%	49,288 $221,000
Q3 2019 Nov 12, 2019	BUY	$2.29 - $7.1 $114,596 - $355,298	50,042 New	50,042 $145,000

Others Institutions Holding AMRX

# of Institutions

184

Shares Held

141M

Call Options Held

57K

Put Options Held

49K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.19B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Amneal Pharmaceuticals, Inc. Transaction History